AzTrials
AzTrials

Neck PainNCT03902119

INYBI Tool in Chronic Neck Pain

A study testing INYBI tool and Manual suboccipital inhibition in people with Neck Pain, run by University of Seville at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objectives: To evaluate the clinical efficacy of using a manual inhibition technique for the suboccipital muscles compared with the use of the so-called INYBI tool in individuals with chronic non-specific neck pain, and the compare the results of using both approaches on pain relief, cervical range of motion neck and… Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Neck Pain
What is being tested?
INYBI tool and Manual suboccipital inhibition
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteSpain
Study dates
24 Apr 2019to 27 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Clinical diagnosis of non-specific mechanical neck pain.
  • Pain of more than 3 months of duration.
  • Pain between the occiput and the third dorsal vertebra.
  • Willingness to participate in the treatment and in the follow-up measurements
  • Neck pain reproduced by neck movements or palpation

Who cannot join

  • Cognitive impairment or inability to communicate.
  • Having received manual therapy in the last two months before recruitment.
  • Having received anti-inflammatory treatment, antidepressants or muscle relaxants in the last 72 hours.
  • Any contraindication to treatment or evaluation procedures.
  • Diagnosis of systemic diseases
  • Diagnosis of fibromyalgia
Show all 10Show fewer
  • Pregnancy
  • Signs of spinal nerve root compression
  • Previous whiplash
  • Any diagnosed possible cause for their neck pain (infection, cancer, spinal stenosis)

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Sevilla

    Seville, 41009

Other trials in Spain

About this study

Official title: Effectiveness of a New Tool (INYBI) in Individuals With Chronic Non-specific Neck Pain.

Objectives: To evaluate the clinical efficacy of using a manual inhibition technique for the suboccipital muscles compared with the use of the so-called INYBI tool in individuals with chronic non-specific neck pain, and the compare the results of using both approaches on pain relief, cervical range of motion neck and vertical maximum mouth opening.

Design: Quantitative, experimental, longitudinal, prospective, and double blinded study.

Read more

Subjects: Patients between 18 and 40 years, with chronic non-specific neck pain of at least 3 months of evolution.

Methods: The experimental group will undergo a 5 minutes intervention for the suboccipital muscles using the INYBI tool. The control group will receive a 5 minutes of treatment involving the suboccipital muscles manual inhibition technique.

Conditions
Neck Pain
Being tested
INYBI tool, Manual suboccipital inhibition
Keywords
neck pain, randomized control trial, manual therapy, physical therapy, suboccipital inhibition
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • INYBI toolDevice

    Patients will lie down in supine position so that the INYBI tool will contact the suboccipital muscles at the posterior arch of the atlas. The therapist will adapt the height of the tool for each individual. All patients will use the softest head of the device. A 50Hz vibration speed will be set sup during 5 minutes.

  • Manual suboccipital inhibitionOther

    Patients will lie down in supine position.The therapist will be seated at the head of the treatment table. The therapist will keep the metacarpophalangeal joints in a flexed position, while therapists fingertips of both hands will contact with the suboccipital muscles at the posterior arch of the atlas.

Study groups in NCT03902119
Study groupRoleWhat they receive
INIBY toolExperimentalPatients will undergo a single treatment session consisting of applying a suboccipital muscle inhibition technique using the so-called INYBI tool. The treatment session will last approximately 5 minutes
Receives: Device: INYBI tool
Manual suboccipital inhibitionActive comparatorPatients will receive a single treatment session consisting of the use of the manual suboccipital muscles inhibition technique.The treatment session will last approximately 5 minutes
Receives: Other: Manual suboccipital inhibition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure pain threshold (PPT) in the evaluated muscles. The PPT levels will be evaluated in Kilograms / cm2

    PPT levels, defined as the minimum necessary pressure to evoke pain will be evaluated using a handheld electronic pressure algometer.

    Measured: From baseline to immediately after treatment.

  2. Active cervical range of movement (ROM). The range of movement will be assessed in degrees

    Flexion, extension, left and right side flexion, and left and right rotation will be assessed using a digital inclinometer.

    Measured: From baseline to immediately after treatment.

  3. Pain free vertical mouth opening. This outcome will be evaluated in centimeters.

    Maximum pain free vertical mouth opening will be assessed using a digital caliper that will place between the incisors 11, 21, 31 y 41.

    Measured: From baseline to immediately after treatment.

  4. Atlas rotation ROM, assessed in degrees

    The atlas bone left and right rotation ROM will be assessed using the flexion-rotation test. For this test, with the participant in supine position, the maximum mobility in head rotation while keeping maximum passive neck flexion will be assessed

    Measured: From baseline to immediately after treatment.

  5. Self-reported pain intensity

    Self-perceived pain intensity will be evaluated during all active cervical movements by a 0 to 10 Visual Analogue Scale (VAS), where 0 denotes no pain at all, and 10 denotes the maximum possible pain

    Measured: From baseline to immediately after treatment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2019
  2. Study start24 Apr 2019
  3. Primary completion27 Sep 2019
  4. Study completion27 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03902119
Sponsor's protocol ID
INYBI tool
Status last verified
Oct 2019
First submitted
27 Mar 2019
Last updated
29 Oct 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing INYBI tool and Manual suboccipital inhibition in people with Neck Pain, run by University of Seville at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure pain threshold (PPT) in the evaluated muscles. The PPT levels will be evaluated in Kilograms / cm2 (time frame: From baseline to immediately after treatment.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in